Active Studies

A Randomized, Open-Label, Phase 3 Study of Abemaciclib combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative Breast Cancer


Enrollment Closed

Electronic Patient Reporting of Symptoms During Outpatient Cancer Treatment: A U.S. National Randomized Controlled Trial (the "PRO-TECT" trial)


Enrolling

A Prospective Blood Sample Collection Study to Develop and Validate a Panel of Protein-based Biomarkers in Patients with Pulmonary Nodules


Enrolling

A Prospective Blood Sample Collection to Evaluate a Panel of Protein-Based Biomarkers


Enrolling

A Phase 3, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Larazotide for Relief of Persistent Symptoms in Patients with Celiac Disease on a Gluten Free Diet


Enrolling

Clinical Evaluation of the BinaxNOW® COVID-19 Antigen (Ag) Card


Enrolling

Diabetic Retinopathy Screening using Smartphone-Based Fundus Photography and Artificial Intelligence. A Proof of Concept Study in a Community Based Clinic


Enrolling

A Phase 3, Multicenter. Randomized, Double-Blind, Placebo-Controlled Induction and Maintenance Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Eosinophilic Esophagitis


Enrolling

Collection and Distribution Non-Small Lung Cancer Plasma for Research Purposes


Enrolling

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing - Ascertaining Serial Cancer Patients to Enable New Diagnostic II (DETECT -ASCEND 2)


Enrolling

STOP-CANCER: Strategic Targeting for Optimal Prevention of Cancer


Enrolling

Correct-MRD II: Seconds Colorectal Cancer Clinical Validation Study to Predict Recurrence Using A Circulating Tumor DNA Assay To Detect Minimal Residual Disease


Enrolling

A Phase 3, Multicenter, Multinational, Open-Label Extension Study to Evaluate the Long-Term Safety of CC-93538 in Adult and adolescent Subjects with Eosinophilic Esophagitis


Enrolling

A multi-center, randomized, placebo-controlled, pragmatic Phase 3 study investigating the efficacy and safety of Rivaroxaban to reduce the risk of major venous and arterial thrombotic event, hospitalization and death in medically ill outpatients with acute symptomatic COVID-19 infection.


Enrolling

A Randomized, double-blind, placebo-controlled, multicentre, Phase 3 study evaluating long-term efficacy and safety pf lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2 (F2)/fibrosis 3 (F3) stage liver fibrosis


Enrolling

A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-

Controlled, Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose of Cilofexor and Firsocostat, Alone and in Combination, in Subjects with Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis )NASH)

Enrolling